EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models

Yan Zhao, Xiuju Wu, Yang Yang, Li Zhang, Xinjiang Cai, Sydney Chen, Abigail Vera, Jaden Ji, Kristina I Boström, Yucheng Yao

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci176758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Yan Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Endothelial Cells, Histone Deacetylase 2, Intracranial Arteriovenous Malformations. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NINDS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral arteriovenous malformations (AVMs) are the most common vascular malformations worldwide and the leading cause of hemorrhagic strokes that may result in crippling neurological deficits. Here, using recently generated mouse models, we uncovered that cerebral endothelial cells (ECs) acquired mesenchymal markers and caused vascular malformations. Interestingly, we found that limiting endothelial histone deacetylase 2 (HDAC2) prevented cerebral ECs from undergoing mesenchymal differentiation and reduced cerebral AVMs. We found that endothelial expression of HDAC2 and enhancer of zeste homolog 1 (EZH1) was altered in cerebral AVMs. These alterations changed the abundance of H4K8ac and H3K27me in the genes regulating endothelial and mesenchymal differentiation, which caused the ECs to acquire mesenchymal characteristics and form AVMs. This investigation demonstrated that the induction of HDAC2 altered specific histone modifications, which resulted in mesenchymal characteristics in the ECs and cerebral AVMs. The results provide insight into the epigenetic impact on AVMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsHistone Deacetylase 2Intracranial Arteriovenous MalformationsAnimalsHumansMiceDisease Models, AnimalMaleFemale

Stichwörter der Autor:innen

Endothelial cellsMouse modelsVascular biology

Substanzen

Hdac2 protein, mouseHistone Deacetylase 2HDAC2 protein, human

Autor:innen und Institutionen

  • Division of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • The Molecular Biology Institute, UCLA, Los Angeles, California, USA.

Förderung

  • NHLBI NIH HHS
  • NINDS NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Zhao, Y., Wu, X., Yang, Y., Zhang, L., Cai, X., Chen, S., Vera, A., Ji, J., Boström, K. I., & Yao, Y. (2024). Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models. Journal of Clinical Investigation. https://doi.org/10.1172/jci176758

Vancouver

Zhao Y, Wu X, Yang Y, Zhang L, Cai X, Chen S, et al. Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models. Journal of Clinical Investigation. 2024. doi:10.1172/jci176758

BibTeX
@article{Zhao2024,
  author = {Zhao, Yan and Wu, Xiuju and Yang, Yang and Zhang, Li and Cai, Xinjiang and Chen, Sydney and Vera, Abigail and Ji, Jaden and Boström, Kristina I and Yao, Yucheng},
  title = {Inhibition of endothelial histone deacetylase 2 shifts endothelial-mesenchymal transitions in cerebral arteriovenous malformation models},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci176758}
}
Kostenlos starten →